Category: Regenerative Medicine
Global Regenerative Medicine
-
Serum-free Media Market Size, Trends, Analysis, and Outlook By Product (Classical Media, Specialty Media, Stem Cell Media, Others), By End-user (Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes, Others), By Application (Bioproduction, Vaccine Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, Others), By Animal Origin, Animal-derived Serum-Free Media, Plant-derived Serum-Free Media, Synthetic Serum-Free Media), By Distribution Channel (Direct Sales, Distributor), by Region, Country, Segment, and Companies, 2024-2030
... Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, Others), By Animal Origin, Animal-derived Serum-Free Media, Plant-derived Serum-Free Media, Synthetic Serum-Free Media), By Distribution Channel (Direct Sales, Distributor), by Region, Country, Segment, and Companies, 2024-2030 ... Read More
-
Human Embryonic Stem Cells Market Size, Trends, Analysis, and Outlook By Application (Regenerative medicine, Stem cell biology research, Tissue engineering, Toxicology testing), by Region, Country, Segment, and Companies, 2024-2030
... market size is poised to register 9.77% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Human Embryonic Stem Cells market across By ... Read More
-
Induced Pluripotent Stem Cells Market Size, Trends, Analysis, and Outlook By Derived Cell Type (Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Others), By Application (Drug Development, Tissue Engineering & Regenerative Medicine, Toxicology Research, Disease Modeling), By End-User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Others), by Region, Country, Segment, and Companies, 2024-2030
... (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Induced Pluripotent Stem Cells market size is poised to register 10.39% growth from 2024 to 2030, presenting ... Read More
-
Veterinary Regenerative Medicine Market Size, Trends, Analysis, and Outlook By Animal Type (Small Animals, Large Animals), By Product (Stem Cells, Others), By Application (Orthopedics, Trauma/Wound Care, Others), By End-user (Veterinary Hospitals/Clinics, Veterinary Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... Region, Country, Segment, and Companies, 2024-2030 The global Veterinary Regenerative Medicine market size is poised to register 16.52% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry ... Read More
-
Induced Pluripotent Stem Cells Production Market Size, Trends, Analysis, and Outlook By Process (Manual iPSC Production Process, Automated iPSC Production Process), By Workflow (Reprogramming, Cell Culture, Cell Characterization / Analysis, Engineering, Others), By Product (Instruments/ Devices, Automated Platforms, Consumables & Kits, Services), By Application (Drug Development and Discovery, Regenerative Medicine, Toxicology Studies, Others), By End-User (Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, Hospitals & Clinics), by Region, Country, Segment, and Companies, 2024-2030
... Devices, Automated Platforms, Consumables & Kits, Services), By Application (Drug Development and Discovery, Regenerative Medicine, Toxicology Studies, Others), By End-User (Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, Hospitals & Clinics), by Region, Country, Segment, ... Read More
-
Stem Cells Market Size, Trends, Analysis, and Outlook By Product (Adult Stem Cells, -Hematopoietic, -Mesenchymal, -Neural, -Epithelial/Skin, -Others, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells), By Application (Regenerative Medicine, -Neurology, -Orthopedics, -Oncology, -Hematology, -Cardiovascular and Myocardial Infraction, -Injuries, -Diabetes, -Liver Disorder, -Incontinence, -Others, Drug Discovery and Development), By Technology (Cell Acquisition, -Bone Marrow Harvest, -Umbilical Blood Cord, -Apheresis, Cell Production, -Therapeutic Cloning, -In-vitro Fertilization, -Cell Culture, -Isolation, Cryopreservation, Expansion and Sub-Culture), By Therapy (Autologous, Allogenic), By Therapy (Pharmaceutical and Biotechnology Companies, Hospitals & Cell Banks, Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... Medicine, -Neurology, -Orthopedics, -Oncology, -Hematology, -Cardiovascular and Myocardial Infraction, -Injuries, -Diabetes, -Liver Disorder, -Incontinence, -Others, Drug Discovery and Development), By Technology (Cell Acquisition, -Bone Marrow Harvest, -Umbilical Blood Cord, -Apheresis, Cell Production, -Therapeutic Cloning, -In-vitro ... Read More
-
Organoids and Spheroids Market Size, Trends, Analysis, and Outlook Organoids By Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, Others), Organoids By Method (General Submerged Method for Organoid Culture, Crypt Organoid Culture Techniques, Air Liquid Interface (ALI) Method for Organoid Culture, Clonal Organoids from Lgr5+ Cells, Brain and Retina Organoid Formation Protocol, Organoids By Source (Primary Tissues, Stem Cells), Spheroids By Type (Multicellular tumor spheroids (MCTS), Neurospheres, Mammospheres, Hepatospheres, Embryoid bodies), Spheroids By Method (Micropatterned Plates, Low Cell Attachment Plates, Hanging Drop Method, Others), Spheroids By Source (Cell Line, Primary Cell, iPSCs Derived Cells), By Application (Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, Drug Toxicity & Efficacy Testing), By End-user (Biotechnology and pharmaceutical industries, Academic & Research Institutes, Hospitals and diagnostic cente
... (ALI) Method for Organoid Culture, Clonal Organoids from Lgr5+ Cells, Brain and Retina Organoid Formation Protocol, Organoids By Source (Primary Tissues, Stem Cells), Spheroids By Type (Multicellular tumor spheroids (MCTS), Neurospheres, Mammospheres, Hepatospheres, Embryoid bodies), ... Read More
-
The 2025-2030 World Outlook for Longevity and Anti-Senescence Therapies
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Stem Cell and Regenerative Medicines
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Biopreservation Equipment and Media
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Human Embryonic Stem Cell (hESC) Regenerative Medicine Research
... year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of ... Read More
-
The 2025-2030 World Outlook for Regenerative Therapies
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Regenerative Medicines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Regenerative Medicine Cell Therapies
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Translational Regenerative Medicines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Bone and Joint Regenerative Medicines
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Biopreservation
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Regenerative Medicine Ceramics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Biopreservation Products and Applications
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
Amniotic Membrane Market - By Product (Cryopreserved, Lyophilized), Application (Surgical Wounds, Ophthalmology, Stem Cell Biology, Regenerative Medicine, Prenatal Diagnosis), End-use (Hospitals, Specialty Clinics) - Global Forecast, 2024 - 2032
... 11.2% CAGR from 2024 to 2032, attributed to advancements in tissue engineering and regenerative medicine technologies, coupled with the growing adoption of amniotic membrane products. These innovations offer promising solutions for wound healing and tissue ... Read More
-
Global Organoids And Spheroids Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Organoids And Spheroids industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Organoids And Spheroids. The report also introduces players ... Read More
-
Global Regenerative Medicine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... USD 115.75 billion by 2029, growing at a CAGR of 24.53% during the forecast period (2024-2029). The COVID-19 pandemic is expected to have a significant impact on the market. The rising COVID-19 cases across the ... Read More
-
Global Biopreservation Equipment Market Growth 2024-2030
... Biopreservation Equipment is forecast to a readjusted size of US$ 970.6 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Biopreservation Equipment market. ... Read More
-
Global Regenerative Medicine Products Market Growth 2024-2030
... the Regenerative Medicine Products is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Regenerative Medicine ... Read More
-
Microcarriers Market - By Products (Consumables {Media, Microcarrier Beads}, Equipment {Bioreactor, Cell Counter}), Application (Biopharmaceutical Production, Regenerative Medicine), End-user (CROs, Research Institutes), Global Forecast, 2024 - 2032
... CAGR during 2024-2032, driven by Increasing adoption of microcarriers in cell culture processes, advancements in R&D activities, expanding applications beyond traditional cell culture processes, and rising demand for cell-based therapies and biologics. Urbanization leads to ... Read More